Three-Month Prevention Follow-Up in 65 Hand-Dermatitis Workers

November 11, 2026

Doctor’s Notes · Life in Motion · Evidence Review

Editorial disclosure: The featured image is an AI-created illustration of a fictional work or daily-life scene. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.

Reader question: What can this study tell workers, families and occupational-health teams—and what would go beyond the evidence? This review keeps every number attached to its population, denominator, comparator and timepoint.

Study snapshot

Study element	Reported detail
Population	143 workers with occupational hand dermatitis were contacted; 101 completed the questionnaire, 65 attended training and clinical reassessment, and 65 people without contact dermatitis formed a control group.
Design	Nonrandomized secondary-prevention follow-up with questionnaire, clinical review and transepidermal water-loss measurements.
Comparator	Participants were compared before and three months after training; adherence subgroups and a 65-person control group were also described.
Timepoint	Baseline training assessment and three-month follow-up.
Key result	Ongoing symptoms decreased from 60.0% to 42.3%. Reported symptom improvement was 61.9% with strict adherence versus 29.0% with partial adherence; hand TEWL changed from 21.3±9.6 to 18.6±7.2 g/m²/h (p=0.001).
Funding/conflict context	The PubMed record lists no grant or conflict-of-interest statement.

What was actually measured?

Ongoing symptoms decreased from 60.0% to 42.3%. Reported symptom improvement was 61.9% with strict adherence versus 29.0% with partial adherence; hand TEWL changed from 21.3±9.6 to 18.6±7.2 g/m²/h (p=0.001).

The paired measurements support improvement over three months, while the adherence comparison is vulnerable to motivation and health-behavior differences. It is not a randomized estimate of one specific component.

The denominator defines the scope. A patch-test clinic, selected case series, compensation registry, online questionnaire, workplace cohort and general-population survey answer different questions. A percentage from one cannot be silently transferred to the others.

What the result does not prove

Only 65 of 143 contacted workers completed training and reassessment, creating selection and attrition concerns. Concurrent treatment, exposure changes and regression to the mean could contribute to improvement.

Association, timing and biological plausibility can strengthen an occupational interpretation, but observational evidence cannot automatically establish individual causation. Referral patterns, reporting practices, task mix, protective equipment, nonwork exposures and access to care may all change an estimate.

A PubMed record is a bibliographic source. PubMed indexing is not NIH endorsement of the authors' conclusions, this interpretation or any product.

Exposure detail matters more than the job label

Workers with the same title can handle different materials for different durations. Useful documentation identifies the exact product or process, the route of contact, glove or PPE material, wetness, friction, heat, dust, splash potential, frequency and how symptoms change away from the task.

A symptom survey can identify a pattern, a clinical examination can refine the differential diagnosis, and patch testing can identify delayed sensitization. None of those steps alone proves that a workplace material caused an individual condition. Clinical relevance still requires a credible exposure and time course.

Questions worth recording

Which task, product, glove, tool, metal, resin, cleanser, food, plant, dust or surface came before symptoms?
Where did the change begin, and did it improve on days away or after a process or PPE change?
How often were hands wet, washed, disinfected, occluded, rubbed, heated or exposed to cold?
Were labels, ingredient information and safety-data sheets reviewed with occupational health?
Did the problem affect dexterity, sleep, pace, attendance, work quality or safety?

Prevention comes before cosmetic care

Substitution, closed systems, local exhaust, splash control, safer cleaning methods, training and correctly selected protective equipment address exposure at its source. Gloves are not automatically protective: material, fit, breakthrough time, sweating, reuse and rubber accelerators all matter.

Do not deliberately place workplace products on skin to test a theory. Persistent, recurrent or spreading symptoms, drainage, fever, breathing symptoms, severe pain, rapidly worsening redness or major loss of function warrant professional evaluation.

Primary research and guidance

Where Dr. Arsy #003 fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003. Its findings do not show that #003 treats, cures or prevents eczema, relieves pain or itch, neutralizes workplace chemicals, is appropriate for every person, or provides pediatric or 24-hour efficacy.

Continue the evidence series

Evidence note: This educational article separates reported findings from interpretation. It is not a diagnosis, treatment recommendation or workplace-safety determination.

← Back to Doctor's Notes